# NIRAVAM
> **NDA021726** · New Drug Application · Sponsor: UCB INC · Approved 2005-01-19
## Drug
- **FDA Application Number:** NDA021726
- **Application type:** New Drug Application
- **Brand name:** NIRAVAM
- **Generic name:** Alprazolam
- **Active ingredients:** ALPRAZOLAM
- **Dosage form:** TABLET, ORALLY DISINTEGRATING
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** UCB INC
- **First approval:** 2005-01-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021726)
---
*AI Analytics · CC0 1.0*